Clinical trial · Interventional
In Vitro Maturation of Immature Oocytes
NCT00480337CI-TRIAL-00001844completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to aspirate immature oocytes from antral follicles and mature the oocytes in vitro. These mature oocytes will serve for fertilization and the creation of embryos which will be replace in the uterus as performed during normal IVF.We will record the efficacy and safety of this procedure.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Hyperstimulation Syndrome | — | UNRESOLVED | — |
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| In Vitro Maturation of immature oocytes | Procedure | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Women with PCOS * Women with previous Hyperstimulation or with risk of developing hyperstimulation during IVF Treatment * Women diagnosed with cancer who are interested in fertility preservation * Women with repeated IVF failure Exclusion Criteria: * Severe cases of endometriosis * Large myomas * Hydrosalpinxs Technical problem with previous oocytes pick-up
References
Publications (0)
Data not yet available
No reference posted for this study.